1. MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression
    Haoming Xia et al, 2015, Biomedicine & Pharmacotherapy CrossRef
  2. MiR-32 promotes tumorigenesis of colorectal cancer by targeting BMP5
    Erfei Chen et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  3. MicroRNA-mediated regulation of BM-MSCs differentiation into sweat gland-like cells: targeting NF-κB
    Yan Chen et al, 2019, Journal of Molecular Histology CrossRef
  4. MicroRNA Signatures in Blood or Bone Marrow Distinguish Subtypes of Pediatric Acute Lymphoblastic Leukemia
    Rekha A Nair et al, 2020, Translational Oncology CrossRef
  5. MicroRNA-based regulation of Aurora A kinase in breast cancer
    Adewale Oluwaseun Fadaka et al, 2020, Oncotarget CrossRef
  6. MiR-32 Functions as a Tumor Suppressor and Directly Targets EZH2 in Human Oral Squamous Cell Carcinoma
    Jin Xiao, 2014, Medical Science Monitor CrossRef
  7. Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma
    Huiqiong Yang et al, 2018, Oncology Letters CrossRef
  8. Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer
    Zhong-Liang Ma et al, 2015, Oncotarget CrossRef
  9. Downregulation of HNF1 homeobox B is associated with drug resistance in ovarian cancer
    JIANCHAO LI et al, 2014, Oncology Reports CrossRef
  10. MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN
    Shi-yan Yan et al, 2015, Tumor Biology CrossRef
  11. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features
    Iman Jahanbani et al, 2018, Thyroid CrossRef
  12. [Retracted] Exosomal miRNA Expression Profiling and the Roles of Exosomal miR‐4741, miR‐32, miR‐3149, and miR‐6727 on Gastric Cancer Progression
    Guojun Tang et al, 2022, BioMed Research International CrossRef
  13. Analysis of miRNA expression profiles in melatonin-exposed GC-1 spg cell line
    Xiaoling Zhu et al, 2018, Gene CrossRef
  14. MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma
    Yuan Zhang et al, 2019, Technology in Cancer Research & Treatment CrossRef
  15. Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin–angiotensin system
    Jacqueline R. Kemp et al, 2014, Journal of Molecular and Cellular Cardiology CrossRef
  16. MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3
    Yanzhao Jin et al, 2019, Journal of Cellular Biochemistry CrossRef
  17. Expression signature of lncRNA APTR in clinicopathology of breast cancer: Its potential oncogenic function in dysregulation of ErbB signaling pathway
    Hosein Mansoori et al, 2021, Gene Reports CrossRef
  18. MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7
    Wei Xia et al, 2017, Cancer Cell International CrossRef
  19. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia
    Zohreh Rahimi et al, 2021, Leukemia Research CrossRef
  20. MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9
    Jian-Qiang Xu et al, 2014, Tumor Biology CrossRef
  21. MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1
    Jiang Yan et al, 2014, Medical Oncology CrossRef
  22. MiR-32 Suppresses the Development of Lung Cancer via Modulating PI3K/Akt
    Qing-Feng Liu et al, 2021, Journal of Biomaterials and Tissue Engineering CrossRef
  23. Naringin protects against steroid‑induced avascular necrosis of the femoral head through upregulation of PPARγ and activation of the Notch signaling pathway
    Donghong Huang et al, 2017, Molecular Medicine Reports CrossRef
  24. MicroRNA-29a Manifests Multifaceted Features to Intensify Radiosensitivity, Escalate Apoptosis, and Revoke Cell Migration for Palliating Radioresistance-Enhanced Cervical Cancer Progression
    Pei-Chin Chuang et al, 2022, International Journal of Molecular Sciences CrossRef